These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8944778)

  • 101. Single-molecule brightness analysis for the determination of anticancer drug interactions with DNA.
    Zhou Y; Bielec K; Pasitsuparoad P; Hołyst R
    Analyst; 2020 Oct; 145(20):6600-6606. PubMed ID: 32785299
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration.
    Demant EJ; Friche E
    Biochem Pharmacol; 1998 Jan; 55(1):27-32. PubMed ID: 9413926
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Spectral shape modifications of anthracyclines bound to cell nuclei: a microspectrofluorometric study.
    Laigle A; Fiallo MM; Garnier-Suillerot A
    Chem Biol Interact; 1996 Jun; 101(1):49-58. PubMed ID: 8665618
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Mechanical and electrokinetic effects of polyamines/phospholipid interactions in model membranes.
    Rudolphi-Skórska E; Zembala M; Filek M
    J Membr Biol; 2014 Jan; 247(1):81-92. PubMed ID: 24337467
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Anthracyclines still prove effective in anticancer therapy.
    Piekarski M; Jelińska A
    Mini Rev Med Chem; 2013 Apr; 13(5):627-34. PubMed ID: 22931532
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding.
    Demant EJ; Friche E
    Biochem Pharmacol; 1998 Nov; 56(9):1209-17. PubMed ID: 9802333
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Towards the predictability of drug-lipid membrane interactions: the pH-dependent affinity of propanolol to phosphatidylinositol containing liposomes.
    Krämer SD; Braun A; Jakits-Deiser C; Wunderli-Allenspach H
    Pharm Res; 1998 May; 15(5):739-44. PubMed ID: 9619783
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The pH-dependence in the partitioning behaviour of (RS)-[3H]propranolol between MDCK cell lipid vesicles and buffer.
    Krämer SD; Wunderli-Allenspach H
    Pharm Res; 1996 Dec; 13(12):1851-5. PubMed ID: 8987083
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours.
    Castaing M; Loiseau A; Dani M
    J Pharm Pharmacol; 2001 Jul; 53(7):1021-8. PubMed ID: 11480537
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Ligand self-association at the surface of liposomes: a complication during equilibrium-binding studies.
    Burke TG; Tritton TR
    Anal Biochem; 1984 Nov; 143(1):135-40. PubMed ID: 6597683
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Role of membrane charge and semiquinone structure on naphthosemiquinone derivatives and 1,4-benzosemiquinone disproportionation and membrane-buffer distribution coefficients.
    Alegría AE; Santiago G; Lópes M; Rosario BI; Cordones E
    Free Radic Res; 2001 Nov; 35(5):529-41. PubMed ID: 11767411
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.
    Madden TD; Harrigan PR; Tai LC; Bally MB; Mayer LD; Redelmeier TE; Loughrey HC; Tilcock CP; Reinish LW; Cullis PR
    Chem Phys Lipids; 1990 Mar; 53(1):37-46. PubMed ID: 1972352
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Path dependence of three-phase or two-phase end points in fluid binary lipid mixtures.
    Lamberson ER; Cambrea LR; Rochet JC; Hovis JS
    J Phys Chem B; 2009 Mar; 113(11):3431-6. PubMed ID: 19243147
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Effects of cholesterol on dye leakage induced by multidrug-resistance modulators from anionic liposomes.
    Castaing M; Loiseau A; Djoudi L
    Eur J Pharm Sci; 2003 Jan; 18(1):81-8. PubMed ID: 12554076
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Thermal dependence of multidrug-resistant-modulator efficiency: a study in anionic liposomes.
    Castaing M; Loiseau A; Dani M
    J Pharm Pharmacol; 2000 Oct; 52(10):1171-8. PubMed ID: 11092560
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Fluorometric determination of the kinetics of anthracyclines uptake by cells.
    Andreoni A; Colasanti A; Kisslinger A; Mastrocinque M; Riccio P; Roberti G
    J Biochem Biophys Methods; 1994 Jan; 28(1):53-68. PubMed ID: 8151070
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Ambazone as a membrane active antitumor drug.
    Löber G; Hoffmann H
    Biophys Chem; 1990 Apr; 35(2-3):287-300. PubMed ID: 2204445
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Preparation of passive bilayer liposomes.
    Zingoni J; Chauhan A; Chauhan VP; Brockerhoff H
    Chem Phys Lipids; 1988 Jan; 46(1):73-7. PubMed ID: 3338101
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Insights into Transfer of Supramolecular Doxorubicin/Congo Red Aggregates through Phospholipid Membranes.
    Stachowicz-Kuśnierz A; Rychlik P; Korchowiec J; Korchowiec B
    Molecules; 2024 May; 29(11):. PubMed ID: 38893446
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Intrinsically Fluorescent Anti-Cancer Drugs.
    Kabir ML; Wang F; Clayton AHA
    Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 36009762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.